CHARITY REGISTRATION NUMBER: 1196513
Sheffield Area Kidney Association Unaudited Financial Statements
31 May 2022
HEBBLETHWAITES
Chartered accountants 2 Westbrook Court Sharrow Vale Road Sheffield S11 8YZ
Sheffield Area Kidney Association
Financial Statements
Year ended 31 May 2022
| Pages | |
|---|---|
| Trustees' annual report | 1 to 7 |
| Independent examiner's report to the trustees | 8 |
| Statement of financial activities | 9 |
| Statement of financial position | 10 |
| Notes to the financial statements | 11 to 17 |
Sheffield Area Kidney Association
Trustees' Annual Report
Year ended 31 May 2022
The trustees present their report and the unaudited financial statements of the charity for the year ended 31 May 2022.
Reference and administrative details
Sheffield Area Kidney Association
Registered charity name Charity registration number 1196513 Principal office 7 Talbot Place Sheffield S2 2SS The trustees
Independent examiner
Mr R Bright Mrs S J Burt Mr D W Marshall Mr P J Beattie Mr P Joynson Mrs G Beattie Mrs K Radford Mrs C J Thompson Mr A Raftery Richard Murdoch FCA 2 Westbrook Court Sharrow Vale Road Sheffield S11 8YZ
Objectives and activities
Sheffield Area Kidney Association (SAKA) was established to offer help and assistance to renal patients and their relatives, and to promote and encourage research into renal disease and kidney failure; and to disseminate the results thereof.
- The objectives of the charity are set out in its governing document, as adopted in November 2021.
Summary of the main activities undertaken for the public benefit in relation to these objectives
In planning our activities for the year we kept in mind the Charity Commissions guidance on public benefit at our trustee meetings:
The focus of our activities remains advancing grants and assistance to renal patients in difficulty (following the advice of the renal social worker) and in awarding grants to the medical profession for studies into renal disease.
In addition we help to keep renal care at the forefront of the mind of the Hospital trust through our attendance at Directorate Management Team meetings.
- 1 -
Sheffield Area Kidney Association
Trustees' Annual Report (continued)
Year ended 31 May 2022
Achievements and performance
In Memoriam: John Powell and Darren Lath
This year we pay particular tribute to two stalwarts of SAKA, John Powell and Darren Lath, who each served for years as Committee members, and who, in their own way, made a significant contribution to the work of our charity, John through many years in key leadership roles helping to shape and guide SAKA, and Darren more recently overseeing our caravan holiday provision and playing a large part in Transplant Games activities.
The COVID-19 pandemic continued to exert a strong influence throughout this period, and accordingly committee members continued to follow national guidance on social distancing, so that all but one of the eleven committee meetings were held virtually, generally using the Zoom meetings platform. This mechanism ensured that the business of the charity was adequately pursued, that finances were regularly reviewed and that development plans were progressed much as normal.
As ever, all meetings were formally recorded in minutes that were properly approved and filed for easy later access if required. These included a note of discussion topics and decisions taken, not least in respect of grant aid for patients, and other expenditures.
The standing agenda includes an activity report from the Chairman and, as required by our Constitution, a financial update from the Treasurer, as well as regular reports on relevant medical and social work issues, including grant applications. Issues of interest or concern are considered on an ad hoc basis, with any necessary action delegated to (a) named individual(s) who subsequently report back to the Committee on progress to ensure that actions are carried through as well as possible, although bureaucracies outside the charity can prove to be frustratingly slow in responding.
The most prominent aspect of business during this year has been our application to become a Charitable Incorporated Organisation (CIO), where the slow progress reported in our last annual report continued, despite employing Wrigleys Solicitors to advise us and ensure the proper preparation and submission of our documentation. The linear nature of this process has determined that once our application had been accepted a further step was required to effect the transfer of assets, to be followed by a a third step, that of securing the original charity as a shell company administered by the CIO, a move necessary to protect any legacy benefits that might accrue to the charity.
As the year drew to a close, SAKA had secured CIO status, and assets had been transferred, but shell company arrangements were still to be agreed. One unanticipated outcome of this protracted process was that the two charities were obliged to work together seamlessly to ensure business continuity. Some work was done on the nature of SAKA's strategic plans once the CIO process had been completed, including a review of our grant-aid policies, together with a proposal to write to all renal patients announcing the changes and inviting their support.
Once again. The committee received only two visitors from the clinical team, both relating to grantaid from SAKA. In June, Dr Karthik Shetty, reported on his experience of the MSc course in Transplantation at Liverpool University, which SAKA was funding until he left Sheffield for a position elsewhere; and, in July, Dr Martin Wilkie spoke about a Home Therapies Fellowship which we subsequently agreed to part-fund alongside the Renal Directorate and the Sheffield Hospitals Charity. Our Financial Adviser, Mr Steven Dilks, also joined us on occasion.
- 2 -
Sheffield Area Kidney Association
Trustees' Annual Report (continued)
Year ended 31 May 2022
Achievements and performance (continued)
The Committee continued to consider requests for grant aid from patients in need, although there were fewer of these than might have been expected. Such requests are generally presented by a member of the specialist Renal Social Work team, who have a standing invitation to join committee meetings, and who supply evidence and background information in support of each request, after which members decide on the amount of grant aid to be given. For the sake of expediency, such requests have come to be be submitted, considered and concluded by digital means, rather than face-to-face, as in the past.
During the year, a total of £3,835 was expended on direct grant aid to individual patients, and included items such as holiday expenses, bedroom furniture, day-to-day living expenses, and, unusually this year, a replacement wig. The 'activity books' previously purchased were distributed to all dialysis units, but with only lukewarm feedback, the decision was taken not to order further supplies. Because of social distancing restrictions, for the second year, there were no Christmas buffets, etc., for patients, but to mark Christmas we once again made a gift of chocolates to the hardworking staff of the Renal Department.
In a unique partnership with the Sheffield and Bedford Lodges of the Royal Antediluvian Order of Buffaloes (RAOB), who raised over £10,400 for this, their chosen charity for the year, SAKA contributed £7,140 towards the cost of providing the renal team with seven hand-held ultrasound scanners, principally for use in vascular investigation and surgery. Particular thanks are due to Grand Master, Mr Paul Templeton, whose participation was crucial in assuring the success of this imaginative collaboration.
Numerous patients have continued to benefit considerably from the ongoing work of Megan Rutter, our benefits adviser provided through our contract with Age UK Sheffield, at an in-year cost of £8,000. We would wish to commend Megan for her unfailing compassion and her holistic approach to those that she helps.
The COVID pandemic and the ensuing recovery programme continued to hinder our plans to honour the life and work of Dr Margaret Platts, and to acknowledge her significant bequest to SAKA. This ambition will be carried forward until eventually circumstances permit it being realised. SAKA met the costs of the Sheffield Transplant Games team this year as a fitting tribute to our deceased colleague, Darren Lath.
SAKA has continued to represent patients, particularly at the monthly meetings of the Renal Directorate Management Team, a collaboration which over the years has helped to develop a shared understanding of our respective positions and issues, and to enable frank and open exchanges when necessary. One issue of note this year was the delay in discharging in-patients, often related to the late arrival of medication, which is a difficulty Trust-wide. Unsurprisingly, the management of the COVID pandemic was the focus of much ongoing discussion. We have continued to explore options for the provision of mental health support for renal patients, and a paper on the matter was presented to the Sheffield Psychology Board, leading to a developing relationship with Sheffield MIND, but the search for viable provision goes on. We also invited suggestions for a suitable means of memorialising Ken Tupling.
- 3 -
Sheffield Area Kidney Association
Trustees' Annual Report (continued)
Year ended 31 May 2022
Achievements and performance (continued)
The Committee has continued to make funds available for local research into renal disease and its treatment, although once again during this year we received no applications to fund such work. As usual,though, through the efforts of Glynis and Phil Beattie we collaborated with our research colleagues in staging an event to mark World Kidney Day in March.
Despite some uncertainty about the effectiveness of the All-Party Parliamentary Kidney Group under its current leadership, and an apparent indifference to examine an issue raised about protective facemasks, SAKA has continued to support the National Kidney Federation (NKF), with committee members Glynis and Phillip Beattie also serving on the NKF Executive Committee. However, we were disappointed that NKF did not take up our offer of a donation to be ring-fenced to a specific project of their choosing.
SAKA has continued to attract funds, and during the year we have received £150,000 by way of bequests, while total donations from regular giving, donations in memory and various fundraising efforts have totalled £21,995. In addition, we received £2,717 through Just Giving, and £845 via Paypal Giving. There was some income from the Transplant Games team which goes into a dedicated fund set aside for that purpose. With relatively few patients attending Sorby Outpatients Department, we were not surprised that Christmas card sales amounted to only £202 this year, but every little helps.
The performance of our investment portfolio was consistent with market place norms, and in common with most other investors we ended the year anticipating better returns when the markets recover from the war in Ukraine and the rising costs of energy. The appointed sub-group of Trustees, guided by advice from RPG Financial, have received quarterly reports on the performance of our investments, and have updated committee colleagues as appropriate. For completeness, we should report that we retained Brewin Dolphin as our investment managers, Mr Steven Dilks, of RPG Financial, mentioned above, as our Financial Adviser, and Hebblethwaites of Sheffield to serve as our accountants.
The membership database has been expanded, if slowly, with efforts hampered by pandemic restrictions, but the SAKA website continues to serve its useful purpose with 13,986 visits during the year, only slightly fewer than the previous year. Our Facebook page continues to prove useful,too.
In summary, although in some respects progress during the year has seemed frustratingly slow, we did nonetheless achieve a signal step forward in becoming a CIO, maintained a strong financial platform, and, we believe, effectively discharged our responsibilities to pursue the objects of our charity.
- 4 -
Sheffield Area Kidney Association
Trustees' Annual Report (continued)
Year ended 31 May 2022
Financial review
The continued kind support of members of the association as well as monies received from those associated with Renal disease is vital to SAKA's ability to continue its works.
Overall the association has recorded a surplus for the year of £96,241 compared to a surplus for the 2021 year end of of £256,671; however, this is after temporary movements on the valuation of long term investments which recorded a loss for the year of £80,527 (2021 £226,660 surplus). The value of these investments was affected, in the 2022 year end, by poor markets as a result of the war in Ukraine and rising energy costs, which was the norm Nationwide.
At the year end SAKA held £297,001 (2021 £143,163) in various bank accounts and had unrestricted funds of £1,410,554 (2021: £1,314,313). These funds are held to ensure SAKA have sufficient resources to meet current commitments as well as to ensure the charitable works of the association can continue.
SAKA hold £12,000 in a reserve fund, included within restricted funds, to ensure the charity can meet one full year of running costs in the case of financial distress.
Plans for future periods
In the coming year SAKA will continue to carry out it's core objectives of offering help and assistance to renal patients and their relatives, and promoting and encouraging research into Renal disease and kidney failure; and to disseminate the results thereof.
- 5 -
Sheffield Area Kidney Association
Trustees' Annual Report (continued)
Year ended 31 May 2022
Structure, governance and management
Charitable Incorporated Organisation status and Merger accounting
For some time, through the good offices of solicitors, Wrigley's LLP, the committee of SAKA, Registered Charity No. 506386, sought to establish the charity as a Charitable Incorporated Organisation. Eventually, having satisfied the Charity Commissioners that their application was sound, the new CIO was formally recognised by the Commissioners on 10th November 2021, (Registered Charity No. 1196513) and this was subsequently recorded in the minutes of the charity on 15th November 2021. It had been anticipated that the new CIO would begin to function soon after this date, but the process of transferring assets from the old to the new charity proved to be unexpectedly protracted, so that, with the approval of the Charity Commissioners, the necessary transfer of assets was not formally concluded until 4th May, 2022, an event again recorded in the minutes of both charities.
Accordingly, being now financially secure, the charity became fully operational on this date, and set out to discharge its obligations as defined by its objects.
Despite the change in legal form, our charity's purpose remains unchanged and for this reason the financial statements have been prepared using Merger accounting, effectively aggregating the assets, liabilities and funds of the combining charities and presenting them as though they had always been part of the same reporting charity. Although the merger took place part way through the reporting period, the accounts must be drawn up to include the results of the combining charities for the whole of the reporting period in which the merger took place.
Note 18 of the financial statements includes the necessary disclosure as required by the Statement of Recommended Practice applicable to charities.
How the charity is constituted
SAKA is a Charitable Incorporated Organisation made up of members and run by it's trustees.
Trustee meetings
The committee of trustees meet monthly to discuss developments in renal care at local hospitals as well as to consider grant and funding requests from patients and the medical profession.
Cash book summaries are produced every month by the Treasurer to enable the committee of trustees to make informed financial decisions that are in the best interest of the charity.
A scheme of delegation is in place and day to day responsibility for the administration of the charity rests with the officers, namely Chairman, Vice-Chairman, Treasurer, Secretary and any such officers as the Annual General Meeting shall determine from time to time.
Recruitment and Training of Trustees
Trustees are appointed based on them having an interest in, and being able to contribute positively to, the objectives of SAKA.
New trustees are inducted to the charity via the monthly meetings held and formal training is available to all trustees where this is deemed appropriate.
Risk Management
- 6 -
Sheffield Area Kidney Association
Trustees' Annual Report (continued)
Year ended 31 May 2022
SAKA reviews its risk profile each year prior to renewing its insurance policy and, where appropriate, systems and procedures have been established to mitigate the risks that SAKA faces.
The trustees' annual report was approved on 21 March 2023 and signed on behalf of the board of trustees by:
Mr D W Marshall Mr P J Beattie Trustee Trustee
- 7 -
Sheffield Area Kidney Association
Independent Examiner's Report to the Trustees of Sheffield Area Kidney Association
Year ended 31 May 2022
I report to the trustees on my examination of the financial statements of Sheffield Area Kidney Association ('the charity') for the year ended 31 May 2022.
Responsibilities and basis of report
As the trustees of the charity you are responsible for the preparation of the financial statements in accordance with the requirements of the Charities Act 2011 (‘the Act’).
I report in respect of my examination of the charity's financial statements carried out under section 145 of the 2011 Act and in carrying out my examination I have followed all the applicable Directions given by the Charity Commission under section 145(5)(b) of the Act.
Independent examiner's statement
I have completed my examination. I confirm that no material matters have come to my attention in connection with the examination giving me cause to believe that in any material respect:
-
accounting records were not kept in respect of the charity as required by section 130 of the Act; or
-
the financial statements do not accord with those records; or
-
the financial statements do not comply with the applicable requirements concerning the form and content of accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the accounts give a ‘true and fair' view which is not a matter considered as part of an independent examination.
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.
Richard Murdoch FCA Independent Examiner
21 March 2023
2 Westbrook Court Sharrow Vale Road Sheffield S11 8YZ
- 8 -
Sheffield Area Kidney Association
Statement of Financial Activities
Year ended 31 May 2022
| 2022 | 2021 | ||||
|---|---|---|---|---|---|
| Unrestricted | Restricted | ||||
| funds | funds | Total funds | Total funds | ||
| Note | £ | £ | £ | £ | |
| Income and endowments | |||||
| Donations and legacies | 4 | 175,558 | – | 175,558 | 28,082 |
| Charitable activities | 5 | 1,325 | – | 1,325 | – |
| Fundraising activities | 6 | 202 | – | 202 | 813 |
| Investment income | 7 | 30,917 | – | 30,917 | 24,459 |
| -------------------------------- | -------------- | -------------------------------- | ---------------------------- | ||
| Total income | 208,002 | – | 208,002 | 53,354 | |
| ================================ | ============== | ================================ | ============================ | ||
| Expenditure | |||||
| Expenditure on raising funds: | |||||
| Charitable activities | 8 | (30,760) | – | (30,760) | (22,593) |
| Other expenditure | 9 | (474) | – | (474) | (750) |
| -------------------------------- | -------------- | -------------------------------- | ---------------------------- | ||
| Total expenditure | (31,234) | – | (31,234) | (23,343) | |
| ================================ | ============== | ================================ | ============================ | ||
| Net (losses)/gains on investments | 10 | (80,527) | – | (80,527) | 226,660 |
| -------------------------------- | -------------- | -------------------------------- | -------------------------------- | ||
| Net income and net movement in | funds | 96,241 | – | 96,241 | 256,671 |
| ================================ | ============== | ================================ | ================================ | ||
| Reconciliation of funds | |||||
| Total funds brought forward | 1,314,313 | 12,000 | 1,326,313 | 1,069,642 | |
| ----------------------------------------- | ---------------------------- | ----------------------------------------- | ----------------------------------------- | ||
| Total funds carried forward | 1,410,554 | 12,000 | 1,422,554 | 1,326,313 | |
| ========================================= | ============================ | ========================================= | ========================================= |
The statement of financial activities includes all gains and losses recognised in the year. All income and expenditure derive from continuing activities.
The notes on pages 11 to 17 form part of these financial statements.
- 9 -
Sheffield Area Kidney Association
Statement of Financial Position
31 May 2022
| 2022 | 2021 | ||
|---|---|---|---|
| Note | £ | £ | |
| Current assets | |||
| Stocks | 13 | 40 | 225 |
| Investments | 14 | 1,132,064 | 1,184,725 |
| Cash at bank and in hand | 297,001 | 143,163 | |
| ----------------------------------------- | ----------------------------------------- | ||
| 1,429,105 | 1,328,113 | ||
| Creditors: amounts falling due within one year | 15 | 6,551 | 1,800 |
| ----------------------------------------- | ----------------------------------------- | ||
| Net current assets | 1,422,554 | 1,326,313 | |
| ----------------------------------------- | ----------------------------------------- | ||
| Total assets less current liabilities | 1,422,554 | 1,326,313 | |
| ----------------------------------------- | ----------------------------------------- | ||
| Net assets | 1,422,554 | 1,326,313 | |
| ========================================= | ========================================= | ||
| Funds of the charity | |||
| Restricted funds | 12,000 | 12,000 | |
| Unrestricted funds | 1,410,554 | 1,314,313 | |
| ----------------------------------------- | ----------------------------------------- | ||
| Total charity funds | 16 | 1,422,554 ========================================= |
1,326,313 ========================================= |
These financial statements were approved by the board of trustees and authorised for issue on 21 March 2023, and are signed on behalf of the board by:
Mr D W Marshall Trustee
Mr P J Beattie Trustee
The notes on pages 11 to 17 form part of these financial statements.
- 10 -
Sheffield Area Kidney Association
Notes to the Financial Statements
Year ended 31 May 2022
1. General information
The charity is a public benefit entity and a registered charity in England and Wales and is unincorporated. The address of the principal office is 7 Talbot Place, Sheffield, S2 2SS.
2. Statement of compliance
These financial statements have been prepared in compliance with FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland', the Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (Charities SORP (FRS 102)) and the Charities Act 2011.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through income or expenditure.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Going concern
There are no material uncertainties about the charity's ability to continue.
Judgements and key sources of estimation uncertainty
The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.
In the opinion of the management and trustees, there are no judgements or key sources of estimation uncertainty that have a significant impact on the financial statements, other than those highlighted below.
Fund accounting
Unrestricted funds are available for use at the discretion of the trustees to further any of the charity's purposes.
Designated funds are unrestricted funds earmarked by the trustees for particular future project or commitment.
Restricted funds are subjected to restrictions on their expenditure declared by the donor or through the terms of an appeal, and fall into one of two sub-classes: restricted income funds or endowment funds.
- 11 -
Sheffield Area Kidney Association
Notes to the Financial Statements (continued)
Year ended 31 May 2022
3. Accounting policies (continued)
Incoming resources
All incoming resources are included in the statement of financial activities when entitlement has passed to the charity; it is probable that the economic benefits associated with the transaction will flow to the charity and the amount can be reliably measured. The following specific policies are applied to particular categories of income:
-
income from donations or grants is recognised when there is evidence of entitlement to the gift, receipt is probable and its amount can be measured reliably.
-
legacy income is recognised when receipt is probable and entitlement is established.
-
income from donated goods is measured at the fair value of the goods unless this is impractical to measure reliably, in which case the value is derived from the cost to the donor or the estimated resale value. Donated facilities and services are recognised in the accounts when received if the value can be reliably measured. No amounts are included for the contribution of general volunteers.
-
income from contracts for the supply of services is recognised with the delivery of the contracted service. This is classified as unrestricted funds unless there is a contractual requirement for it to be spent on a particular purpose and returned if unspent, in which case it may be regarded as restricted.
Resources expended
Expenditure is recognised on an accruals basis as a liability is incurred. Expenditure includes any VAT which cannot be fully recovered, and is classified under headings of the statement of financial activities to which it relates:
-
expenditure on raising funds includes the costs of all fundraising activities, events, noncharitable trading activities, and the sale of donated goods.
-
expenditure on charitable activities includes all costs incurred by a charity in undertaking activities that further its charitable aims for the benefit of its beneficiaries, including those support costs and costs relating to the governance of the charity apportioned to charitable activities.
-
other expenditure includes all expenditure that is neither related to raising funds for the charity nor part of its expenditure on charitable activities.
All costs are allocated to expenditure categories reflecting the use of the resource. Direct costs attributable to a single activity are allocated directly to that activity. Shared costs are apportioned between the activities they contribute to on a reasonable, justifiable and consistent basis.
Stocks
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stock to its present location and condition.
- 12 -
Sheffield Area Kidney Association
Notes to the Financial Statements (continued)
Year ended 31 May 2022
3. Accounting policies (continued)
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument.
Basic financial instruments are initially recognised at the amount receivable or payable including any related transaction costs, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.
Current assets and current liabilities are subsequently measured at the cash or other consideration expected to be paid or received and not discounted.
Debt instruments are subsequently measured at amortised cost.
4. Donations and legacies
| Unrestricted | Total Funds | Unrestricted | Total Funds | ||
|---|---|---|---|---|---|
| Funds | 2022 | Funds | 2021 | ||
| £ | £ | £ | £ | ||
| Donations | |||||
| Donations | 25,558 | 25,558 | 7,641 | 7,641 | |
| Legacies | |||||
| Legacy Bequests | 150,000 | 150,000 | 20,441 | 20,441 | |
| -------------------------------- | -------------------------------- | ---------------------------- | ---------------------------- | ||
| 175,558 | 175,558 | 28,082 | 28,082 | ||
| ================================ | ================================ | ============================ | ============================ | ||
| 5. | Charitable activities | ||||
| Unrestricted | Total Funds | Unrestricted | Total Funds | ||
| Funds | 2022 | Funds | 2021 | ||
| £ | £ | £ | £ | ||
| Income from Transplant Games | 1,325 | 1,325 | – | – | |
| ======================= | ======================= | ============== | ============== | ||
| 6. | Fundraising activities | ||||
| Unrestricted | Total Funds | Unrestricted | Total Funds | ||
| Funds | 2022 | Funds | 2021 | ||
| £ | £ | £ | £ | ||
| Christmas Card Sales | 202 | 202 | 813 | 813 | |
| ============== | ============== | ============== | ============== | ||
| 7. | Investment income | ||||
| Unrestricted | Total Funds | Unrestricted | Total Funds | ||
| Funds | 2022 | Funds | 2021 | ||
| £ | £ | £ | £ | ||
| Income from listed investments | 30,866 | 30,866 | 24,384 | 24,384 | |
| Bank Interest Received | 51 | 51 | 75 | 75 | |
| ---------------------------- | ---------------------------- | ---------------------------- | ---------------------------- | ||
| 30,917 ============================ |
30,917 ============================ |
24,459 ============================ |
24,459 ============================ |
- 13 -
Sheffield Area Kidney Association
Notes to the Financial Statements (continued)
Year ended 31 May 2022
8. Charitable activities
| Unrestricted | Total Funds | Unrestricted | Total Funds | |
|---|---|---|---|---|
| Funds | 2022 | Funds | 2021 | |
| £ | £ | £ | £ | |
| Social Work Fund | 291 | 291 | – | – |
| Patient Aid | 3,835 | 3,835 | 2,967 | 2,967 |
| Hospital Projects | 7,140 | 7,140 | 4,427 | 4,427 |
| Insurance | 325 | 325 | 193 | 193 |
| Bank Charges | 177 | 177 | 134 | 134 |
| Printing and postage | 53 | 53 | 99 | 99 |
| Independent Examiners Fee | 1,800 | 1,800 | 1,800 | 1,800 |
| Benefits adviser consultancy fees | 8,000 | 8,000 | 8,000 | 8,000 |
| Legal fees | 9,139 | 9,139 | 4,973 | 4,973 |
| ---------------------------- | ---------------------------- | ---------------------------- | ---------------------------- | |
| 30,760 ============================ |
30,760 ============================ |
22,593 ============================ |
22,593 ============================ |
9. Other expenditure
| Unrestricted | Total Funds | Unrestricted | Total Funds | |
|---|---|---|---|---|
| Funds | 2022 | Funds | 2021 | |
| £ | £ | £ | £ | |
| Christmas Cards | 185 | 185 | 422 | 422 |
| Miscellaneous Expenses | 289 | 289 | 328 | 328 |
| -------------- | -------------- | -------------- | -------------- | |
| 474 | 474 | 750 | 750 | |
| ============== | ============== | ============== | ============== | |
| Net (losses)/gains on investments | ||||
| Unrestricted | Total Funds | Unrestricted | Total Funds | |
| Funds | 2022 | Funds | 2021 | |
| £ | £ | £ | £ | |
| Gains/(losses) on listed investments | (80,527) ============================ |
(80,527) ============================ |
226,660 ================================ |
226,660 ================================ |
10. Net (losses)/gains on investments
11. Independent examination fees
Fees payable to the independent examiner for: Independent examination of the financial statements
| 2022 | 2021 |
|---|---|
| £ | £ |
| 1,800 ======================= |
1,800 ======================= |
12. Trustee remuneration and expenses
No remuneration is paid to the trustees for their services and no trustee expenses have been incurred.
13. Stocks
Raw materials and consumables
| 2022 | 2021 |
|---|---|
| £ | £ |
| 40 | 225 |
| ============== | ============== |
- 14 -
Sheffield Area Kidney Association
Notes to the Financial Statements (continued)
Year ended 31 May 2022
14. Investments
| 2022 | 2021 | |
|---|---|---|
| £ | £ | |
| Other investments | 1,132,064 ========================================= |
1,184,725 ========================================= |
Investments are managed on behalf of SAKA by independent third party managers. £1,123,202 (2021 £1,170,167) is invested directly in listed shares/securities and £8,863 (2021 £14,558) is held as cash awaiting investment.
15. Creditors: amounts falling due within one year
| 2022 | 2021 | |
|---|---|---|
| £ | £ | |
| Accruals and deferred income | 6,551 ======================= |
1,800 ======================= |
16. Analysis of charitable funds
Unrestricted funds
| At | Gains and | At | ||||
|---|---|---|---|---|---|---|
| 1 Jun 2021 | Income | Expenditure | Transfers | losses | 31 May 2022 | |
| £ | £ | £ | £ | £ | £ | |
| General funds | 1,314,313 | 208,002 | (31,234) | – | (80,527) | 1,410,554 |
| ========================================= | ================================ | ============================ | ============== | ============================ | ========================================= | |
| At | Gains and | At | ||||
| 1 Jun 2020 | Income | Expenditure | Transfers | losses | 31 May 2021 | |
| £ | £ | £ | £ | £ | £ | |
| General funds | 1,024,261 | 53,354 | (23,343) | 33,381 | 226,660 | 1,314,313 |
| ========================================= | ============================ | ============================ | ============================ | ================================ | ========================================= |
- 15 -
Sheffield Area Kidney Association
Notes to the Financial Statements (continued)
Year ended 31 May 2022
16. Analysis of charitable funds (continued)
Restricted funds
| Restricted funds | ||||||
|---|---|---|---|---|---|---|
| At | Gains and | At | ||||
| 1 Jun 2021 | Income | Expenditure | Transfers | losses | 31 May 2022 | |
| £ | £ | £ | £ | £ | £ | |
| Kim Pollard | ||||||
| Research Fund | – | – | – | – | – | – |
| Renal & | ||||||
| Transplant | ||||||
| Satellite Units | ||||||
| Funds | – | – | – | – | – | – |
| Heeley Dialysis | – | – | – | – | – | – |
| Operating Costs | ||||||
| Reserve Fund | 12,000 | – | – | – | – | 12,000 |
| ---------------------------- | -------------- | -------------- | -------------- | -------------- | ---------------------------- | |
| 12,000 | – | – | – | – | 12,000 | |
| ============================ | ============== | ============== | ============== | ============== | ============================ | |
| At | Gains and | At | ||||
| 1 Jun 2020 | Income | Expenditure | Transfers | losses | 31 May 2021 | |
| £ | £ | £ | £ | £ | £ | |
| Kim Pollard | ||||||
| Research Fund | 31,104 | – | – | (31,104) | – | – |
| Renal & | ||||||
| Transplant | ||||||
| Satellite Units | ||||||
| Funds | 1,894 | – | – | (1,894) | – | – |
| Heeley Dialysis | 383 | – | – | (383) | – | – |
| Operating Costs | ||||||
| Reserve Fund | 12,000 | – | – | – | – | 12,000 |
| ---------------------------- | -------------- | -------------- | ---------------------------- | -------------- | ---------------------------- | |
| 45,381 ============================ |
– ============== |
– ============== |
(33,381) ============================ |
– ============== |
12,000 ============================ |
17. Analysis of net assets between funds
| Unrestricted | Restricted | Total Funds | |
|---|---|---|---|
| Funds | Funds | 2022 | |
| £ | £ | £ | |
| Current assets | 1,410,554 | 12,000 | 1,422,554 |
| ========================================= | ============================ | ========================================= | |
| Unrestricted | Restricted | Total Funds | |
| Funds | Funds | 2021 | |
| £ | £ | £ | |
| Current assets | 1,314,313 | 12,000 | 1,326,313 |
| ========================================= | ============================ | ========================================= |
- 16 -
Sheffield Area Kidney Association
Notes to the Financial Statements (continued)
Year ended 31 May 2022
18. Merger Accounting
Disclosures relating to merger required by the Charities Sorp S27.14-S27.16. In these tables SAKA and SAKA CIO refer to the charities with registration numbers 506386 and 1196513 respectively.
Table 1 : Analysis of principal SoFA components for the current reporting period (£)
| Total Income Total Expenditure Net income/(expenditure) Other gains/(losses) Net movement in funds |
SAKA SAKA CIO SAKA CIO Combined (pre-merger) (pre-merger) (post-merger) Total £ £ £ £ 207,424 - 578 208,002 (31,000) - (234) (31,234) |
|---|---|
176,424 - 344 176,768 (80,527) - - (80,527) 95,897 - 344 96,241 |
Table 2 : Analysis of principal SoFA components for the previous reporting period (£)
| Total Income Total Expenditure Net income/(expenditure) Other gains/(losses) Net movement in funds |
SAKA SAKA CIO Combined Total £ £ £ 53,354 - 53.354 (23,343) - (23,343) |
|---|---|
30,011 - 30,011 226,660 - 226,660 |
|
256,671 - 256,671 |
Table 3 : Analysis of net assets at the date of merger (£)
| Net Assets Represented by: Unrestricted funds Restricted funds Total funds |
SAKA SAKA CIO Combined Total £ £ £ 1,422,210 - 1,422,210 1,410,210 - 1,410,210 12,000 - 12,000 |
|---|---|
| 1,422,210 - 1,422,210 |
19. Related parties
There were no transactions with related parties during either the 2022 and 2021 year ends.
- 17 -